Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anamika Singh Gaur

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Structural Chemistry|September 12, 2022
Computational screening for investigating the synergistic regulatory potential of drugs and phytochemicals in combination with 2-deoxy-D-glucose against SARS-CoV-2Anshika Gupta, Shweta Singh Chauhan, Anamika Singh Gaur, et al.
In Silico Pharmacology|February 19, 2024
Cytokines inhibitory mechanism of <i>Prunus domestica</i> L. (Plum) peptides as potential immunomodulators against systemic lupus erythematosus: an in-silico screeningAnshika Gupta, Tanya Jamal, Priyanka Rajbhar, et al.
Expert Opinion on Drug Discovery|April 24, 2023
Galaxy for open-source computational drug discovery solutionsAnamika Singh Gaur, Selvaraman Nagamani, Lipsa Priyadarsinee, et al.
Journal of Biomedical Informatics|August 10, 2018
Molecular property diagnostic suite for diabetes mellitus (MPDS<sup>DM</sup>): An integrated web portal for drug discovery and drug repurposingAnamika Singh Gaur, Selvaraman Nagamani, Karunakar Tanneeru, et al.
Computers in Biology and Medicine|September 23, 2021
Molecular descriptor analysis of approved drugs using unsupervised learning for drug repurposingSita Sirisha Madugula, Lijo John, Selvaraman Nagamani, et al.
Molecular Diversity|August 4, 2022
Towards systematic exploration of chemical space: building the fragment library module in molecular property diagnostic suiteAnamika Singh Gaur, Lijo John, Nandan Kumar, et al.
Journal of Chemical Sciences (Bangalore, India)|May 2, 2022
Applying polypharmacology approach for drug repurposing for SARS-CoV2Esther Jamir, Himakshi Sarma, Lipsa Priyadarsinee, et al.
Gigabyte (Hong Kong, China)|March 25, 2024
Molecular Property Diagnostic Suite for COVID-19 (MPDS<sup>COVID-19</sup>): an open-source disease-specific drug discovery portalLipsa Priyadarsinee, Esther Jamir, Selvaraman Nagamani, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Structural Chemistry|September 12, 2022
Computational screening for investigating the synergistic regulatory potential of drugs and phytochemicals in combination with 2-deoxy-D-glucose against SARS-CoV-2Anshika Gupta, Shweta Singh Chauhan, Anamika Singh Gaur, et al.
In Silico Pharmacology|February 19, 2024
Cytokines inhibitory mechanism of <i>Prunus domestica</i> L. (Plum) peptides as potential immunomodulators against systemic lupus erythematosus: an in-silico screeningAnshika Gupta, Tanya Jamal, Priyanka Rajbhar, et al.
Expert Opinion on Drug Discovery|April 24, 2023
Galaxy for open-source computational drug discovery solutionsAnamika Singh Gaur, Selvaraman Nagamani, Lipsa Priyadarsinee, et al.
Journal of Biomedical Informatics|August 10, 2018
Molecular property diagnostic suite for diabetes mellitus (MPDS<sup>DM</sup>): An integrated web portal for drug discovery and drug repurposingAnamika Singh Gaur, Selvaraman Nagamani, Karunakar Tanneeru, et al.
Computers in Biology and Medicine|September 23, 2021
Molecular descriptor analysis of approved drugs using unsupervised learning for drug repurposingSita Sirisha Madugula, Lijo John, Selvaraman Nagamani, et al.
Molecular Diversity|August 4, 2022
Towards systematic exploration of chemical space: building the fragment library module in molecular property diagnostic suiteAnamika Singh Gaur, Lijo John, Nandan Kumar, et al.
Journal of Chemical Sciences (Bangalore, India)|May 2, 2022
Applying polypharmacology approach for drug repurposing for SARS-CoV2Esther Jamir, Himakshi Sarma, Lipsa Priyadarsinee, et al.
Gigabyte (Hong Kong, China)|March 25, 2024
Molecular Property Diagnostic Suite for COVID-19 (MPDS<sup>COVID-19</sup>): an open-source disease-specific drug discovery portalLipsa Priyadarsinee, Esther Jamir, Selvaraman Nagamani, et al.
Pageof 1